Nonprofit Societies Should Be Open To Scrutiny By Their Members And By The Press

We live in a society in which public, private, and nonprofit institutions co-exist in a competitive environment. Ironically, in the world's most for-profit free enterprise society, nonprofit institutions abound. There is an endless variety of them recognized by our tax laws. Most nonprofits are tax-exempt. They range from religious to educational to professional societies. In exchange for this status, they must give up some of the privileges of being private or commercial. Public corporations,

Written byEugene Garfield
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

We live in a society in which public, private, and nonprofit institutions co-exist in a competitive environment. Ironically, in the world's most for-profit free enterprise society, nonprofit institutions abound. There is an endless variety of them recognized by our tax laws. Most nonprofits are tax-exempt. They range from religious to educational to professional societies. In exchange for this status, they must give up some of the privileges of being private or commercial. Public corporations, as distinct from privately owned enterprises, must disclose to their stockholders information on salaries and other compensation of their executives.

As implied recently in the Washington-based newsletter Science & Government Report (Dec. 15, 1989, page 1), professional societies have not always been completely forthcoming about compensation for their executives. In some cases, the only way journalists are able to obtain this information is to request IRS Form 990, which must be filed annually with the Internal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies